日期 | 股東名稱 | 披露原因 | 買入/賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
10/01/2025 | Luye Life Sciences Group Ltd | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Luye Life Sciences Group Ltd | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | 刘殿波 | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | 刘殿波 | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Life Sciences Group Ltd | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Luye Pharma Holdings Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Shorea LBG | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Ginkgo (PTC) Limited | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Nelumbo Investments Limited | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Ginkgo (PTC) Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Nelumbo Investments Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Life Sciences Group Ltd | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Pharma Holdings Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Shorea LBG | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Pharma Holdings Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Shorea LBG | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Nelumbo Investments Limited | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Ginkgo (PTC) Limited | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | 刘殿波 | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | 刘殿波 | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Ginkgo (PTC) Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Shorea LBG | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | UBS Group AG | 1703(L) 1402(S) | +74,000,500(L) +37,000,000(S) | 505,171,643(L) 477,583,143(S) | 13.43 12.70 | |
10/01/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | LuYe Pharmaceutical International Co., Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Pharma Holdings Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Nelumbo Investments Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | LuYe Pharmaceutical International Co., Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
07/01/2025 | UBS Group AG | 1213(L) 1402(S) | -9,886,500(L) +92,028,711(S) | 443,106,171(L) 449,660,971(S) | 11.78 11.95 | |
03/01/2025 | UBS Group AG | 1305(L) | 68,623,827(L) | 456,292,400(L) 360,935,000(S) | 12.13 9.60 | |
02/01/2025 | UBS Group AG | 1104(L) 1502(S) | +9,105,000(L) -82,994,302(S) | 460,222,164(L) 365,536,264(S) | 12.23 9.72 | |
26/12/2024 | UBS Group AG | 1205(L) | -499,083(L) | 451,269,014(L) 449,603,523(S) | 11.99 11.95 | |
25/12/2024 | UBS Group AG | 1104(L) | +877,500(L) | 451,690,097(L) 450,006,098(S) | 12.01 11.96 | |
24/12/2024 | UBS Group AG | 1205(L) 1502(S) | -9,398,369(L) -9,398,369(S) | 444,198,366(L) 442,514,367(S) | 11.81 11.76 | |
20/12/2024 | UBS Group AG | 1402(S) | +2,693,500(S) | 456,601,225(L) 453,596,218(S) | 12.14 12.06 | |
1 2 3 4 5 |
備註: | (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。 |
(S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。 | |
(P) - 可供借出的股份 | |
即時報價更新時間為 17/01/2025 09:45 | |
港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
新聞
股票
期貨期權N
權證
ETF
A股
外匯黃金
加密貨幣
基金
MPF